Clinical trials recruiting for Urothelial Cancer
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Maryland | 2 |
| Massachusetts | 2 |
| New York | 2 |
| Texas | 2 |
| Colorado | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Michigan | 1 |
| New Jersey | 1 |
Top cities
Self-screener
Recruiting trials
- A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
- A Phase 1a/1b, First-Time-in-Human Study of CT-202, a Nectin-4 Directed Bispecific Antibody, in Participants With Recurring Triple Negative Breast, Colorectal, Urothelial Cancers
- A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- DK222 Study at Hopkins
- Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Related conditions
Trials recruiting for Urothelial Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Urothelial Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.